Teva- Pharmaceutical Industries Ltd. ADR (TEVA)’s stock is trading at $19.12 at the moment marking a rise of 4.20% from the last session close. As of this writing, shares are priced at -16.14% less than their 52-week high of $22.80, and 53.39% over their 52-week low of $12.47.
Further, it is important to consider TEVA stock ratios, particularly its price-to-sales ratio over the past twelve months, which stands at 1.31.Likewise, its price to free cash flow for the last twelve months stands at 18.45. TEVA’s price to book ratio for the most recent quarter was 3.21, resulting in an 10.15 price to cash per share for the period.
How does Teva- Pharmaceutical Industries Ltd. ADR (TEVA) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1.
Teva- Pharmaceutical Industries Ltd. ADR (TEVA): Earnings History
If we examine Teva- Pharmaceutical Industries Ltd. ADR’s recent earnings history, in the last quarter ended on 6/30/2025, it posted adjusted earnings per share of $0.66, slashing the consensus of $0.62. In other words, it topped the consensus by $0.04, resulting in a 7.31% surprise. In the 3 months period before the previous quarter which was closed on 6/30/2025, the stock recorded adjusted earnings per share of $0.66 in contrast with the Outlook of $0.62. That was a difference of $0.04 and a surprise of 7.31%.
Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) Ownership Details
I will give a breakdown of the key shareholders in Teva- Pharmaceutical Industries Ltd. ADR (TEVA). Recent figures show that the company’s insiders hold 0.00% of shares. A total of 747 institutional investors hold shares in the company, making 65.04% of its stock and 65.04% of its float.
Jul 31, 2025, it was reported that the Company’s largest institutional holder is iShares Trust-iShares Core MSCI EAFE ETF holding total of 7.44 shares that make 0.65% of the company’s total number of shares and are currently priced at 142.48 million.
The securities firm Fidelity Contrafund holds 6.66 shares of TEVA, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 0.58%, and the holding percentage of shares is valued at 127.54 million.
